“…The emergence of microarray technologies leading to high-throughput discovery of novel gene expression changes has been beneficial in building signaling pathways (42); however, the measurement of RNA expression is still a step removed from protein pathways critical for signaling. To overcome this caveat, proteomics has advanced over recent years to allow development of highthroughput discovery studies through utilization of advanced technologies in exploring cascades of signaling events by analyzing cellular phosphoproteome, protein-protein interactions, DNA-protein interactions, and quantitative protein abundance under varying conditions or disease models (11,26,27,35,41,44,46,48). Methods such as immunoisolation and protein biotin labeling to purify protein signaling complexes, followed by MS analysis have been commonly used to explore signaling pathways (26,27,41); however, these methods are not ideal in all conditions.…”